does the va cover glp-1 Is healthcare approving prescriptions? Semaglutide (GLP-1) Weight Loss Treatment
Description
At 52 weeks, patients who reached and maintained the target dose of semaglutide (2.4 mg weekly) lost 14.8% of baseline weight
The medications have also been shown to reduce complications from kidney disease, improve heart and liver health, treat sleep apnea in overweight adults, and even protect the brain
This article was originally published on 08.05.2025 and updated on 17.02.2026
while no definite relationship had been established, the FDA was reportedly considering additional changes to the drug's labeling
